Cargando…
An arrayed CRISPR screen reveals Myc depletion to increase productivity of difficult-to-express complex antibodies in CHO cells
Complex therapeutic antibody formats, such as bispecifics (bsAbs) or cytokine fusions, may provide new treatment options in diverse disease areas. However, the manufacturing yield of these complex antibody formats in Chinese Hamster Ovary (CHO) cells is lower than monoclonal antibodies due to challe...
Autores principales: | Bauer, Niels, Oswald, Benedikt, Eiche, Maximilian, Schiller, Lisa, Langguth, Emma, Schantz, Christian, Osterlehner, Andrea, Shen, Amy, Misaghi, Shahram, Stingele, Julian, Ausländer, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700384/ https://www.ncbi.nlm.nih.gov/pubmed/36452067 http://dx.doi.org/10.1093/synbio/ysac026 |
Ejemplares similares
-
A proteomic study of cMyc improvement of CHO culture
por: Kuystermans, Darrin, et al.
Publicado: (2010) -
Generation of genetically engineered CHO cell lines to support the production of a difficult to express therapeutic protein
por: Laux, Holger, et al.
Publicado: (2013) -
Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins
por: Malm, Magdalena, et al.
Publicado: (2022) -
A novel hydrogen peroxide evolved CHO host can improve the expression of difficult to express bispecific antibodies
por: Mistry, Rajesh K., et al.
Publicado: (2021) -
cMyc increases cell number through uncoupling of cell division from cell size in CHO cells
por: Kuystermans, Darrin, et al.
Publicado: (2009)